
James Scott Andrews MD
Clinical Fellow, Internal Medicine, UCSF School of Medicine
Join to View Full Profile
2000 6th Ave SBirmingham, AL 35233
Phone+1 205-934-9999
Are you Dr. Andrews?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Andrews, MD is a rheumatologist in Birmingham, Alabama. He is currently licensed to practice medicine in Alabama, Washington, and California. He is a Clinical Fellow at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 2012 - 2014
- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
- Stanford University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - Present
- AL State Medical License 2023 - 2025
- WA State Medical License 2015 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Epidemiology of myositis.Fnu Duremala, Eleni Tiniakou, James Andrews
Current Opinion in Rheumatology. 2025-03-01 - Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil, James S Andrews, Pankti Reid
Rheumatology. 2025-02-12 - 3 citationsAssessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection: A Randomized Phase 2 Trial of RSLV-132.James S Andrews, Jim B Boonyaratanakornkit, Eva Krusinska, Suzanne Allen, James A Posada
Clinical Infectious Diseases. 2024-09-26
Press Mentions
- Drugmakers, Scientists Begin the Hunt for Long COVID TreatmentsMarch 26th, 2022
- Drugmakers, Scientists Begin the Hunt for Long COVID TreatmentsMarch 25th, 2022
- Tackling the Unknowns of Long-Haul COVID-19January 26th, 2022